Mesenteric lymph nodes in MR enterography: are they reliable followers of bowel in active Crohn’s disease?

2018 ◽  
Vol 28 (10) ◽  
pp. 4429-4437 ◽  
Author(s):  
Amir Reza Radmard ◽  
Rana Eftekhar Vaghefi ◽  
Seyed Ali Montazeri ◽  
Sara Naybandi Atashi ◽  
Amir Pejman Hashemi Taheri ◽  
...  
2003 ◽  
Vol 27 (2) ◽  
pp. 220-227 ◽  
Author(s):  
Laura W. Lamps ◽  
K. T. Madhusudhan ◽  
Jennifer M. Havens ◽  
Joel K. Greenson ◽  
Mary P. Bronner ◽  
...  

2019 ◽  
Vol 10 ◽  
Author(s):  
Marwa Bsat ◽  
Laurence Chapuy ◽  
Manuel Rubio ◽  
Ramses Wassef ◽  
Carole Richard ◽  
...  

1984 ◽  
Vol 71 (8) ◽  
pp. 623-625 ◽  
Author(s):  
N. S. Ambrose ◽  
Margaret Johnson ◽  
D. W. Burdon ◽  
M. R. B. Keighley

2007 ◽  
Vol 56 (3) ◽  
pp. 233-241 ◽  
Author(s):  
Marleen I. Verstege ◽  
Fiebo J. W. ten Kate ◽  
Susanne M. Reinartz ◽  
Cornelis M. van Drunen ◽  
Frederik J. M. Slors ◽  
...  

Dendritic cells (DCs) are key cells in innate and adaptive immune responses that determine the pathophysiology of Crohn's disease. Intestinal DCs migrate from the mucosa into mesenteric lymph nodes (MLNs). A number of different markers are described to define the DC populations. In this study we have identified the phenotype and localization of intestinal and MLN DCs in patients with Crohn's disease and non-IBD patients based on these markers. We used immunohistochemistry to demonstrate that all markers (S-100, CD83, DC-SIGN, BDCA1-4, and CD1a) showed a different staining pattern varying from localization in T-cell areas of lymph follicles around blood vessels or single cells in the lamina propria and in the MLN in the medullary cords and in the subcapsular sinuses around blood vessels and in the T-cell areas. In conclusion, all different DC markers give variable staining patterns so there is no marker for the DC.


1986 ◽  
Vol 409 (5) ◽  
pp. 679-692 ◽  
Author(s):  
K. Geboes ◽  
J. Oord ◽  
C. Wolf-Peeters ◽  
V. Desmet ◽  
P. Rutgeerts ◽  
...  

2019 ◽  
Vol 14 (3) ◽  
pp. 393-405 ◽  
Author(s):  
Laurence Chapuy ◽  
Marwa Bsat ◽  
Manuel Rubio ◽  
François Harvey ◽  
Vinicius Motta ◽  
...  

Abstract Background and Aims Crohn’s disease [CD] and ulcerative colitis [UC] are distinct forms of inflammatory bowel disease. Heterogeneity of HLA-DR+SIRPα + mononuclear phagocytes [MNPs], including macrophages [MΦ], monocyte-derived [Mono] cells, and dendritic cells [DCs], was reported in gut tissue but not yet investigated in mesenteric lymph nodes [MLNs] of IBD patients. We here compared the phenotype, function, and molecular profile of HLA-DR+SIRPα + MNPs in CD and UC MLNs. Methods Cell distribution, morphology, immune function, and transcriptomic [bulk RNAseq] and high-dimensional protein expression profiles [CyTOF] of HLA-DR+SIRPα + MNPs were examined in MLNs of UC [n = 14], CD [n = 35], and non-IBD [n = 12] patients. Results Elevated frequencies of CD14+CD64+CD163+ [Mono/MΦ-like] MNPs displaying monocyte/MΦ morphology and phagocytic function were a distinct feature of UC MLNs. In CD, the proportion of CD14-CD64-CD163- [DC-like] cells was augmented relative to Mono/MΦ-like cells; DC-like cells drove naïve T cell proliferation, Th1 polarisation, and Th17 TCM plasticity. Gene expression profile corroborated the nature of DC-like cells, best represented by BTLA, SERPINF, IGJ and, of Mono/MΦ-like cells, defined by CD163, MARCO, MAFB, CD300E, S100A9 expression. CyTOF analysis showed that CD123+ plasmacytoid cells predominated over conventional DCs in DC-like cells. Four CD163+ clusters were revealed in Mono/MΦ-like cells, two of which were enriched in MARCO-CD68dimHLA-DRdim monocyte-like cells and MARCOhiCD68hiHLA-DRhi Mɸ, whose proportion increased in UC relative to CD. Conclusions Defining the landscape of MNPs in MLNs provided evidence for expansion of CD163+ Mono/MΦ-like cells in UC only, highlighting a distinction between UC and CD, and thus the potential contribution of monocyte-like cells in driving colitis.


Sign in / Sign up

Export Citation Format

Share Document